After PARPi treatment for 6 days, the tumor organoids from the xenograft models of the BRCA2 hypermethylated patient showed a decline in tumor cell nuclei, in contrast to the organoids with BRCA wildtype, but similar to the BRCA1 mutated organoids (Fig. 2). Here, BRCA2 is linked to neoplasm.